logo
Share SHARE
FONT-SIZE Plus   Neg

After-market Movers For April 18 (EBAY, FFIV, VMW, QCOM, YUM, MLNX)

Gainers:

eBay Inc. (EBAY) rose over 6 percent to $38.12. The company's first quarter profit improved from the previous year, on a 29 percent growth in revenues. Both earnings per share and revenue were above analysts' estimates. For the second quarter, the company expects adjusted per share in-line with Wall Street view, but revenue below consensus.

F5 Networks, Inc. (FFIV) gained 3 percent to $127.70 as the company's second quarter earnings and revenue increased from the year-ago quarter and were above consensus.

VMware, Inc. (VMW) increased 3 percent to $114.50. The company's first quarter profit increased from the year-ago quarter. Revenues improved 25.1 percent. Both earnings and revenues were above Wall Street view. The company expects revenues for the second quarter and 2012 in-line with consensus.

Mellanox Technologies, Ltd. (MLNX) rose 13 percent to $48.89. The company swung to a profit in its first quarter. Non-GAAP earnings per share were sharply above analysts' expectation. Revenue rose 61.2 percent and were above consensus.

Decliners:

QUALCOMM Inc. (QCOM) declined over 3 percent to $64.81. The company's second quarter profit and revenues surged from the previous year. Both non-GAAP earnings per share and revenues were above Wall Street view. However, the company expects third quarter and fiscal 2012 non-GAAP earnings per share below consensus.

Yum! Brands, Inc. (YUM) fell 1 percent to $72.25. The company's first quarter profit increased from the previous year and adjusted earnings per share topped analysts' estimate. Total revenues grew 14 percent and were also above consensus. In its China division, system sales increased 28 percent, prior to foreign currency translation and same-store sales increased 14 percent.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Rare commodities are worth more than good is a Chinese adage. And more so when it is in the sought-after drug space. Rare and ultra-rare diseases, also called orphan and ultra-orphan diseases, as the names imply, affect very small numbers of patients. So why the clamor? Shares of steel giant ArcelorMittal were losing around 4 percent in the early morning trading in Amsterdam after the company reported sharp decline in first-quarter EBITDA, a key earnings metric, as sales were weak with lower prices and production. Net loss, however, narrowed from last year. The company also confirmed its forecast for annual EBITDA, which is lower than last year. As the din settles down on a dismal quarter at one of the world's exciting tech company, it is time to sit back and take stock of what went wrong and will the wrong be righted in the near term?
comments powered by Disqus
Follow RTT